Investor

Foresite Capital

A multi-stage healthcare and life sciences investment firm using a data-driven approach

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, funding companies across different stages of their life cycle in areas of unmet medical need. It describes its approach as data science-driven, aiming to combine technology and biotech expertise to identify shifts in the sector before they become widely apparent. Its portfolio has included Eikon Therapeutics, a clinical-stage biopharmaceutical company that the firm says it supported from an early concept through its later growth. Testimonials on its site reference the firm's involvement in projects addressing cancer treatment resistance and the combination of healthcare data in a privacy-compliant way.

Summary written by TrustList from the business's own published information, Sep 2026.

Gallery

2 images - click to enlarge

Categories & features

Rankings

Foresite Capital is ranked on 2 TrustList rankings: #31 on 1 and #49 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Foresite Capital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Investor · 2 rankings

#31of 52
Biotech investors
It is one of 14 here listing healthtech.
Of the 52 here, 14 also cover seed stage and 14 also cover healthtech; 15 also work in Boston and 12 also work in New York City.
Behind Enterprise Ireland, ahead of Formic Ventures.
#49of 92
Healthtech investors
It is one of 11 here listing biotech.
Of the top 62 here, 17 also cover artificial intelligence and 13 also cover partners; 12 also work in London and 10 also work in San Francisco.
Behind Flare Capital Partners, ahead of Gilde Healthcare.